CCR2 and neoplasm: Thus, recent studies in the orthotopic Hepa1-6 HCC mouse model identify the CCL2/CCR2 axis as critical for HSPC recruitment to the spleen of tumor bearing mice, and establish its effective suppression by CCR2 antagonists (50).